Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes
When Washington returned from its winter holiday break in January, it seemed everyone was talking about lowering drug prices.
Emmarie Huetteman
Democrats Taking Key Leadership Jobs Have Pocketed Millions From Pharma
Three lawmakers who will lead the U.S. House next year are among the biggest recipients of campaign contributions from the pharmaceutical industry.
Three of the lawmakers who will lead the House next year as Congress focuses on skyrocketing drug costs are among the biggest recipients of campaign contributions from the pharmaceutical industry, a new KHN analysis shows.
House Dems In New Seats Of Power Will Steer Health Policy, Attack Drug Prices
But Republicans’ tightened grip on the Senate means those hoping for another round of dramatic, progressive reforms may be disappointed.
For the first time since passing the Affordable Care Act, Democrats will soon control the House of Representatives and its powerful health committees. But Republicans’ tightened grip on the Senate means those hoping for another round of dramatic, progressive reforms may be disappointed.
McCain Hated The ACA But Also Saved It
Shortly after his cancer diagnosis, he thwarted the Republican party's attempt to overturn the Affordable Care Act.
There are many lawmakers who made their names in health care, seeking to usher through historic changes to a broken system.
John McCain was not one of them.
Reed College Grad's Plan for Transgender Surgery Caught in Political Crosswinds
The election of President Donald Trump had a big impact on transgender people, peeling back health care protections.
With the country on course to enshrine the rights of transgender Americans, Wren Vetens introduced herself as a woman for the first time in January 2016, at the annual meeting of the American Astronomical Society.
